Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder.

Published in: ClinicoEconomics and outcomes research : CEOR (2019)

Significantly lower medical costs were observed in patients with MDD treated with brexpiprazole vs quetiapine XR.

Keyphrases